Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly.
The report details the trend, potential and market size of Acromegaly Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acromegaly Therapeuticsmarket, defines the market attractiveness level of Acromegaly Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acromegaly Therapeutics industry, describes the types of Acromegaly Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acromegaly Therapeutics market and the development prospects and opportunities of Acromegaly Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acromegaly Therapeutics market in Chapter 13.
By Player:
Pfizer
IPSEN
Novartis
By Type:
Octreotide
Pasireotide
Lanreotide
Pegvisomant
By End-User:
Hospital
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acromegaly Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acromegaly Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acromegaly Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acromegaly Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acromegaly Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Acromegaly Therapeutics Consumption (2017-2022)
-
7.2 United States Acromegaly Therapeutics Consumption (2017-2022)
-
7.3 Europe Acromegaly Therapeutics Consumption (2017-2022)
-
7.4 China Acromegaly Therapeutics Consumption (2017-2022)
-
7.5 Japan Acromegaly Therapeutics Consumption (2017-2022)
-
7.6 India Acromegaly Therapeutics Consumption (2017-2022)
-
7.7 South Korea Acromegaly Therapeutics Consumption (2017-2022)
8 Region and Country-wise Acromegaly Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Acromegaly Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Acromegaly Therapeutics Consumption Forecast (2022-2028)
9 Global Acromegaly Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Acromegaly Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Octreotide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pasireotide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lanreotide Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pegvisomant Consumption and Growth Rate (2017-2022)
-
9.2 Global Acromegaly Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Acromegaly Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Acromegaly Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pegvisomant Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acromegaly Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Acromegaly Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acromegaly Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acromegaly Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acromegaly Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acromegaly Therapeutics Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Acromegaly Therapeutics Product and Service
-
14.2 IPSEN
-
14.2.1 IPSEN Company Details
-
14.2.2 IPSEN Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 IPSEN Acromegaly Therapeutics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Acromegaly Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acromegaly Therapeutics
-
Figure Acromegaly Therapeutics Picture
-
Table Global Acromegaly Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acromegaly Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acromegaly Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acromegaly Therapeutics Consumption by Country (2017-2022)
-
Figure United States Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acromegaly Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Acromegaly Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acromegaly Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Octreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Pasireotide Consumption and Growth Rate (2017-2022)
-
Figure Global Lanreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Pegvisomant Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pegvisomant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acromegaly Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acromegaly Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Acromegaly Therapeutics Product and Service
-
Table IPSEN (Foundation Year, Company Profile and etc.)
-
Table IPSEN Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table IPSEN Acromegaly Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Acromegaly Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Acromegaly Therapeutics Product and Service
-
